medical decision support medical decision support
Sign In

Risk Factors of Fann et al for Delirium in a Patient Undergoing Myeloablative Hematopoietic Stem Cell Transplant

Description

Fann et al identified risk factors for delirium in patients undergong myeloablative hematopoietic stem cell transplants. These can help to identify a patient who may benefit from closer monitoring and early interventions for delirium. The authors are from the University of Washington in Seattle, the Ohio State University and Arizon Medical Psychology (Scottsdale).


 

The incidence of delirium was 50% in the study population.

 

Risk factors for delirium onset:

(1) high pretransplant serum alkaline phosphatase

(2) high pretransplant BUN

(3) higher opioid dose after the transplant

 

Risk factors for delirium severity:

(1) high pretransplant serum alkaline phosphatase

(2) high pretransplant BUN

(3) worse pretransplant executive function

(4) higher opioid dose after the transplant

(5) higher levels of pain after the transplant

(6) higher post-transplant BUN

 


To read more or access our algorithms and calculators, please log in or register.

Specialty